Level Bio AB (publ) (NGM:LEVBIO)
Sweden
· Delayed Price · Currency is SEK 0.4000
+0.0160 (4.17%)
At close: May 13, 2025
Level Bio AB Revenue
Level Bio AB had revenue of 6.42M SEK in the quarter ending September 30, 2024, with 0.06% growth. This brings the company's revenue in the last twelve months to 23.74M, down -20.75% year-over-year. In the year 2023, Level Bio AB had annual revenue of 26.10M, down -23.99%.
Revenue (ttm)
23.74M
Revenue Growth
-20.75%
P/S Ratio
1.15
Revenue / Employee
2.16M
Employees
13
Market Cap
27.36M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 26.10M | -8.24M | -23.99% |
| Dec 31, 2022 | 34.33M | -9.63M | -21.91% |
| Dec 31, 2021 | 43.96M | 20.43M | 86.86% |
| Dec 31, 2020 | 23.53M | 6.45M | 37.77% |
| Dec 31, 2019 | 17.08M | -1.05M | -5.80% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Investor AB | 104.49B |
| Atlas Copco AB | 176.63B |
| AB Volvo | 517.43B |
| ASSA ABLOY AB | 152.90B |
| EQT AB | 30.39B |
| Skandinaviska Enskilda Banken AB | 79.55B |
| Swedbank AB | 73.90B |
| Sandvik AB | 123.18B |